Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19
Marcel S. Woo,
Friedrich Haag,
Axel Nierhaus,
Dominik Jarczak,
Kevin Roedl,
Christina Mayer,
Thomas T. Brehm,
Marc van der Meirschen,
Annette Hennigs,
Maximilian Christopeit,
Walter Fiedler,
Panagiotis Karagiannis,
Christoph Burdelski,
Alexander Schultze,
Samuel Huber,
Marylyn M. Addo,
Stefan Schmiedel,
Manuel A. Friese,
Stefan Kluge,
Julian Schulze zur Wiesch
Affiliations
Marcel S. Woo
Institute of Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany
Friedrich Haag
Department of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany
Axel Nierhaus
Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany
Dominik Jarczak
Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany
Kevin Roedl
Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany
Christina Mayer
Institute of Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany
Thomas T. Brehm
I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany; German Center for Infection Research (DZIF), University Medical Center Hamburg-Eppendorf, Lübeck - Borstel - Riems, Hamburg, Germany
Marc van der Meirschen
I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany
Annette Hennigs
I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany
Maximilian Christopeit
Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany
Walter Fiedler
Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, II. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany
Panagiotis Karagiannis
Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, II. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany
Christoph Burdelski
Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany
Alexander Schultze
Department of Emergency Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany
Samuel Huber
I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany
Marylyn M. Addo
I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany; German Center for Infection Research (DZIF), University Medical Center Hamburg-Eppendorf, Lübeck - Borstel - Riems, Hamburg, Germany
Stefan Schmiedel
I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany; German Center for Infection Research (DZIF), University Medical Center Hamburg-Eppendorf, Lübeck - Borstel - Riems, Hamburg, Germany
Manuel A. Friese
Institute of Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany; Corresponding author
Stefan Kluge
Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany
Julian Schulze zur Wiesch
I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany; Corresponding author
Summary: COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicative of organ damage that correlated with disease severity, particularly affecting kidneys, hepatobiliary system, and immune landscape. By performing unsupervised clustering and trajectory analysis, we identified T and B cell depletion as early indicators of a complicated disease course. In addition, markers of hepatobiliary damage emerged as robust predictor of lethal outcome in critically ill patients. This allowed us to propose a novel clinical COVID-19 SeveriTy (COST) score that distinguishes complicated disease trajectories and predicts lethal outcome in critically ill patients.